Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bertucci

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survivalF Bertucci, N T Ueno, P Finetti, et al.
Bone Marrow Transplantation|January 17, 2017
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantationL Boudin, A Gonçalves, R Sabatier, et al.
ESMO Open|July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgeryP Pautier, A Floquet, C Chevreau, et al.
Oncogene|July 26, 2011
A refined molecular taxonomy of breast cancerM Guedj, L Marisa, A de Reynies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2025
Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trialJ-Y Blay, Q Devin, M Toulmonde, et al.
ESMO Open|July 25, 2021
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)D Dano, A Lardy-Cleaud, A Monneur, et al.
Nature Medicine|May 26, 2022
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohortA Italiano, A Bessede, M Pulido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancerF Mosele, B Stefanovska, A Lusque, et al.
Nature Structural & Molecular Biology|May 14, 2020
SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbationsA Takedachi, E Despras, S Scaglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2012
Genomic grade adds prognostic value in invasive lobular carcinomaO Metzger-Filho, S Michiels, F Bertucci, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survivalF Bertucci, N T Ueno, P Finetti, et al.
Bone Marrow Transplantation|January 17, 2017
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantationL Boudin, A Gonçalves, R Sabatier, et al.
ESMO Open|July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgeryP Pautier, A Floquet, C Chevreau, et al.
Oncogene|July 26, 2011
A refined molecular taxonomy of breast cancerM Guedj, L Marisa, A de Reynies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2025
Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trialJ-Y Blay, Q Devin, M Toulmonde, et al.
ESMO Open|July 25, 2021
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)D Dano, A Lardy-Cleaud, A Monneur, et al.
Nature Medicine|May 26, 2022
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohortA Italiano, A Bessede, M Pulido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancerF Mosele, B Stefanovska, A Lusque, et al.
Nature Structural & Molecular Biology|May 14, 2020
SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbationsA Takedachi, E Despras, S Scaglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2012
Genomic grade adds prognostic value in invasive lobular carcinomaO Metzger-Filho, S Michiels, F Bertucci, et al.
Pageof 12